Navigation
Public engagement

Virus Fighter

Build a virus or fight a pandemic!

Play online

Maya's Marvellous Medicine

Read online for free

Print your own copy

Battle Robots of the Blood

Read online for free

Print your own copy

Just for Kids! All about Coronavirus

Read online for free

Print your own copy

Archive
LabListon on Twitter

Entries in Coronvavirus (17)

Thursday
Apr162020

Smoking and coronavirus

"Coronavirus science simplified" edition 4. This paper looks at the expression of the protein ACE2 in smokers and ex-smokers. Why is this important? Read the pre-print (like a scientific paper, but it hasn't been reviewed yet - consider it a preliminary result), or see the illustrated abstract from TenMei:

 

Wednesday
Apr152020

Should you wear a face-mask?

The third paper in our series on "Coronavirus science simplified". The talented TenMei is taking cutting-edge papers on Coronavirus and boiling them down to an illustrated abstract. Today's paper is "Respiratory virus shedding in exhaled breath and efficacy of face mask". You can read the original here, with the key message simplified:

Friday
Apr102020

Just for KIDS! All about Coronavirus

Are you struggling to explain COVID-19 to your kids? Together with Tenmei, we wrote a new kids book to explain what Coronavirus is, how it makes us sick, and why we are in lockdown.

"Just for KIDS! All about Coronavirus"

Suitable for 6-14 year old kids, the book is certified as scientifically accurate by Prof Hedgehog! The story is free on Issuu for everyone to read.

Also available in Spanish.

Tuesday
Mar312020

When will we have a Coronavirus vaccine?

Vaccines are very unusual medicines. Most medications are developed for the purpose of treating sick people. Vaccines, on the other hand, are developed for the purpose of treating healthy people, ideally for an infection that most people won't get exposed to. This means that vaccine development is in one way much harder than any other drug. This is because every medication needs to do more good than harm to the person receiving it. A drug designed to treat a disease has an easy cost-benefit ratio to achieve: if that disease is serious and the drug is effective in at least some people, then even relatively frequent adverse effects may be tolerated. In the case of vaccines, however, because you are treating healthy people the cost-benefit ratio means you can almost never have any substantial adverse effects and the vaccine has to work in almost every person. Add on to this the fact that vaccines are designed to give ideally life-long protection. A drug for a disease might be acceptable if it worked if taken once a day. A vaccine should give at least 10 years of protection, although there are a few exceptions. Plus vaccines are most effective when everyone gets them, meaning you need to be able to mass produce them for almost nothing and they should be stable even without cold storage, etc. In short, vaccines are exceptionally difficult to make because they have to be nearly perfect before they get approved.

On the other hand, vaccines are easier to make than most other drugs. For most drugs, we first need to understand the molecular basis of disease in incredible detail, down to the atomic precision of the key proteins. Only then can we start to design small molecules that disrupt pathology, with a long and painful process of screening and improving that leaves most drug candidates dead before they hit a trial. Even once we get into patients, we are still highly likely to find that the drugs do more harm than good, or are only effective in a handful of patients. Vaccines, on the other hand, are not really drugs at all. You can best think of a vaccine as a trigger to instruct the body on how to make its own natural drugs, antibodies. The more we know about a virus the better we can design the vaccine trigger, but a lot of the best vaccines just come from randomly blasted bits of dead virus. There are exceptions, where the viruses biology works against us. HIV and herpes viruses are really difficult to make vaccines against, because they hide out inside our body. Fortunately, COVID-19 looks like a fairly standard virus in this respect, and is unlikely to be unusually problematic. There are already promising small-scale trials indicating that antibodies against COVID-19 would work. These were done by taking antibodies from a recovered patient and injecting it into the sick patient, but the principle is the same. There is still some concern that COVID-19 may be more complicated, based on some results indicating that recovered people can get reinfected, but at the moment this is most likely due to false negative screening rather than a true re-infection. It does need to be considered though - we just don't know enough about the biology to be sure.

With vaccines being both harder and easier to make than other drugs, how long will it be before we get a vaccine? Here I don't have any inside commercial knowledge, but it seems very likely that we will have a vaccine developed, tested and approved in 2020. The key here is that the cost-benefit ratio is completely different for a COVID-19 vaccine than it is for a normal vaccine. As I said, normal vaccines have to be almost perfect before they are approved, with any serious side-effects resulting in the vaccine being shelved. During a global pandemic, however, the risk of adverse effects needs to be balanced against the advantage of moving fast. Let's say we got a vaccine that only worked in 50% of people and caused minor adverse effects (sore arm for a week) in 10% of people. Right now, who wouldn't line up to get vaccinated? 

So expect a poor vaccine in 2020, assuming that immunologists are given sufficient funding to develop it. It will skip a lot of the normal safety and efficacy steps, and it will likely not protect everyone and possibly cause side-effects. That said, it would still be a useful tool for controlling a pandemic. Then towards the end of 2021 I would expect to see the roll-out of better vaccines, with higher levels of efficacy and fewer adverse effects. At some point in the future, every child will likely be given a vaccine for COVID-19 as part of their routine vaccination schedule, but that is much more likely to be a third- or forth-generation vaccine, with the optimal properties that we expect.

Sunday
Mar292020

Hydroxychloroquine + azithromycin is not a treatment for COVID-19

The second paper in our series on "Coronavirus science simplified". The talented TenMei is taking cutting-edge papers on Coronavirus and boiling them down to an illustrated abstract. Today's paper is "Hydroxychloroquine and azithromycin as a treatment of COVID-19". You can read the original here, but watch out - the study is seriously flawed and these drugs are not recommended. See the key messages simplified:

Friday
Mar272020

Virus Outbreak simulator

The Liston lab has collaborated with Dr Simon Andrews at Babraham Bioinformatics to create an interactive model of virus outbreak spreading. We are asking for feedback on this beta version, try it out and tweet to us at Virus Break.

To play Virus Outbreak, pick a virus (Coronavirus, flu, ebola or measles) and simulate a viral outbreak in the community. The default settings are based on real medical data, but you can modify the viral properties - change the virulence (rate of new infections), lethality, incubation period and symptomatic period. Find out why an ebola virus with the virulence of measles is the worst nightmare of virologists, run simulations of flu vs Coronavirus to see why medical experts are sounding the alarm. 

In Virus Outbreak, you don't only control the virus, you control the response against the virus. Let the virus run free to create "herd immunity", or pick between vaccination, quarantine or social distancing to see what difference they can make. Change your mind on the policy? Hit "stop", go into properties to change the policy, then go back and hit "start" to see how the simulation changes. Take a look at this video where we start social distancing after the outbreak is already established:

New infections grind to a halt. It takes a week for the death rate to drop, because there are asymptomatic people built into the system, but it works! Give it a try here.

Wednesday
Mar252020

Coronavirus treatment implicates the immune system as killer

The first paper in our series on "Coronavirus science simplified". The talented TenMei is taking cutting-edge papers on Coronavirus and boiling them down to an illustrated abstract. Today's paper is"Effective Treatment of Severe COVID-19 Patients with Tocilizumab". You can read the original here, or see the key messages simplified:

Page 1 2